BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38523188)

  • 1. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
    Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
    Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an
    Huang J; Li T; Tang L; Hu Y; Hu Y; Gu Y
    Acad Radiol; 2024 Jun; ():. PubMed ID: 38845294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
    BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.
    Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R
    Eur J Surg Oncol; 2024 Jun; 50(7):108450. PubMed ID: 38843660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT radiomics nomogram predicts pathological response after induced chemotherapy and overall survival in patients with advanced laryngeal cancer: A single-center retrospective study.
    Kang C; Sun P; Yang R; Zhang C; Ning W; Liu H
    Front Oncol; 2023; 13():1094768. PubMed ID: 37064100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
    Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
    Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jan; ():. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072).
    Liu W; Zeng C; Wang S; Zhan Y; Huang R; Luo T; Peng G; Wu Y; Qiu Z; Li D; Wu F; Chen C
    Front Oncol; 2022; 12():1026305. PubMed ID: 37078004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
    Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
    Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 18. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
    Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
    Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Prediction of Perineural Invasion in Oesophageal Squamous Cell Carcinoma Based on CT Radiomics Nomogram: A Multicenter Study.
    Zhou H; Zhou J; Qin C; Tian Q; Zhou S; Qin Y; Wu Y; Shi J; Feng F
    Acad Radiol; 2024 Apr; 31(4):1355-1366. PubMed ID: 37949700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients.
    Wang F; Zhao Y; Xu J; Shao S; Yu D
    Front Oncol; 2022; 12():1037672. PubMed ID: 36518321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.